年龄70±5岁与局限性前列腺癌治疗后的肿瘤特异性结局:一项系统综述
该系统综述检索1999年1月1日至2023年1月30日PubMed文献,纳入45项研究(30项根治性前列腺切除术、15项外照射放疗),评估年龄( cutoff 70±5岁)与治疗类型对肿瘤特异性结局的交互作用。根治性前列腺切除术研究中10项(50%)提示高龄与更差结局相关,无研究提示高龄为有利预后因素;外照射放疗研究中8项(53%)提示高龄与更好结局相关,另3项(21%)趋势支持更好结局,无研究提示高龄为不良预后因素。作者认为年龄≥70岁可能是根治性前列腺切除术的不良预后因素、外照射放疗的有利预后因素,需进一步研究验证。
要点
- 根治性前列腺切除术研究中10项(50%)提示高龄与更差结局相关,无研究提示高龄为有利因素。
- 外照射放疗研究中8项(53%)提示高龄与更好结局相关,另3项(21%)趋势支持更好结局。
- 作者认为年龄70±5岁可能是RP不良预后因素、EBRT有利预后因素,需进一步研究验证。
核心结论
- 该系统综述提示,以70±5岁为分类界值时,年龄可能是接受根治性前列腺切除术男性的不良预后因素,而是接受外照射放疗男性的有利预后因素。
- 作者指出需进一步研究以验证这些发现。
研究设计与样本
- 系统综述,检索PubMed 1999年1月1日至2023年1月30日文献,评估年龄对根治性局部治疗(RP或EBRT)后肿瘤特异性结局的影响。
- 共纳入45项研究,其中30项为根治性前列腺切除术患者研究,15项为外照射放疗患者研究。
主要发现
- 根治性前列腺切除术研究中,10项(50%)提示高龄与更差结局相关,无研究提示年龄为有利预后因素。
- 外照射放疗研究中,8项(53%)提示高龄与更好结局相关,另3项(21%)趋势支持更好结局,无研究提示高龄为不良预后因素。
局限性
- 作者指出需进一步研究以验证这些发现。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A secondary analysis of 2 randomized Radiation Therapy Oncology Group trials demonstrated that age ≥70 years was a favorable prognostic factor among men treated with external beam radiation therapy (EBRT). In contrast, several series based on men undergoing radical prostatectomy (RP) suggested that older age was an unfavorable prognostic factor. Our study was initiated to determine whether these observations reflect a true but paradoxical underlying age-related treatment-dependent biological phenomenon. We conducted a systematic review (PubMed, January 1, 1999-January 30, 2023) evaluating the effect of age on cancer-specific outcomes after definitive local treatment with either RP or EBRT. Our main objective was to assess possible interactions between age (using a cutoff of 70 +/- 5 years) and treatment type, with regard to adverse cancer-specific outcomes (eg, pathology, biochemical failure, distant metastasis, or prostate cancer-specific survival). Forty-five studies were selected for inclusion in this systematic review, including 30 and 15 studies with patients treated with RP and EBRT, respectively. Among patients treated with RP, 10 (50%) of these studies suggested that older age was associated with worse outcome(s) after RP. None suggested that age was a favorable prognostic factor after RP. Among the EBRT-based studies, 8 (53%) suggested that older age was associated with better outcomes, with an additional 3 studies (21%) trending to support a better outcome. None of these studies involving EBRT suggested that older age was an adverse prognostic factor. This systematic review suggests that age using a categorical cutoff of 70 +/- 5 years may be an adverse prognostic factor for men undergoing RP but a favorable prognostic factor for men treated with EBRT. Further research is needed to validate these findings.
引用
- Shaheen H, Salans MA, Mohamad O, et al. Age 70 +/- 5 Years and Cancer-Specific Outcomes After Treatment of Localized Prostate Cancer: A Systematic Review. Int J Radiat Oncol Biol Phys. 2023. PMID: 37788716. doi:10.1016/j.ijrobp.2023.09.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。